Literature DB >> 15633404

Proliferative diabetic retinopathy: pathophysiology of extraretinal complications and principles of vitreous surgery.

R G Michels1.   

Abstract

Extraretinal complications of proliferative diabetic retinopathy are caused by neovascular and/or fibrovascular tissue growth and include vitreous hemorrhage, retinal detachment, and other effects damaging the retina and/or optic nerve. Exact features of fibrovascular tissue growth and secondary complications vary widely from case to case. However, the structural pathogenesis of this disease process is consistent because the abnormal tissue nearly always grows along the posterior vitreous surface. Therefore, differing topographic features and secondary complications are dependent on: (1) the places of origin and amount of fibrovascular proliferation, and (2) the location and extent of any posterior vitreous separation. The latter influences the configuration of the fibrovascular tissue growth and determines the effect on the underlying and adjacent retina. Surgical treatment of proliferative diabetic retinopathy is based on this fundamental structural pathophysiology. The -principles of surgery are to minimize damaging effects by reversing the optical and structural complications and preventing recurrence of similar problems. Therefore, the objectives of surgery are to remove any intravitreal opacities and to excise the posterior vitreous surface. To achieve these objectives, various specialized techniques are required, depending on the complexity of the vitreoretinal anatomy in each case. Still, when the objectives are achieved, the operation has similar beneficial immediate and long-term effects in most eyes. This paper discusses and illustrates the structural pathology of proliferative diabetic retinopathy and the principles and methods of surgical therapy, and it presents the results obtained and the complications encountered.

Entities:  

Mesh:

Year:  1981        PMID: 15633404

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

1.  Vitrectomy for traction macular detachment in diabetic retinopathy.

Authors:  P Meier; P Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

2.  Intravitreal Bevacizumab for the Treatment of Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy.

Authors:  Rupin N Parikh; Anastasia Traband; Anton M Kolomeyer; Brian L VanderBeek; Benjamin J Kim; Albert M Maguire; Alexander J Brucker
Journal:  Am J Ophthalmol       Date:  2017-01-24       Impact factor: 5.258

3.  Comparison of microinsicion vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy.

Authors:  Reiji Yokota; Makoto Inoue; Yuji Itoh; Tosho Rii; Kazunari Hirota; Akito Hirakata
Journal:  Jpn J Ophthalmol       Date:  2015-07-23       Impact factor: 2.447

4.  Randomized clinical trial of intraocular silicone vs. gas in the management of complicated retinal detachment and vitreous hemorrhage.

Authors:  G A Peyman; G W Kao; L R de Corral
Journal:  Int Ophthalmol       Date:  1987-08       Impact factor: 2.031

5.  Intravitreal injection of bevacizumab and gas for diabetic premacular hemorrhage with active fibrovascular proliferation.

Authors:  Chih-Wei Shih; Chung-May Yang; Muh-Shy Chen; Tsung-Jen Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-06       Impact factor: 3.117

6.  Outcomes of vitrectomy for diabetic tractional retinal detachment in Chicago's county health system.

Authors:  Jared T Sokol; Sidney A Schechet; Darin T Rosen; Kevin Ferenchak; Sherif Dawood; Dimitra Skondra
Journal:  PLoS One       Date:  2019-08-20       Impact factor: 3.240

7.  Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.

Authors:  Ahmed Hosni Abd Elhamid; Ahmed Abd El Alim Mohamed; Abeer Mohamed Khattab
Journal:  BMC Ophthalmol       Date:  2020-04-06       Impact factor: 2.209

8.  A proposed new classification for diabetic retinopathy: the concept of primary and secondary vitreopathy.

Authors:  Arvind Kumar Dubey; Pran Nath Nagpal; Shobhit Chawla; Benu Dubey
Journal:  Indian J Ophthalmol       Date:  2008 Jan-Feb       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.